Home/ Stocks/ VIR

Vir Biotechnology, Inc. Common Stock

VIR XNAS

$9.70 +0.19 (+1.93%) ▲ 15-min delayed

Open

$9.39

High

$9.72

Low

$9.39

Volume

52.5K

Market Cap

$1.54B

About Vir Biotechnology, Inc. Common Stock

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 367 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$-29,000	$-125,695,000	$-0.85
FY 2025	$68.56M	$-437,987,000	$-3.16
Q3 2025	$240.0K	$-163,141,000	$-1.17
Q2 2025	$1.21M	$-110,958,000	$-0.80

TickerDaily Coverage

Why Is Vir Biotechnology, Inc. Common Stock (VIR) Stock Up 55.4% Today?

Market News Sarah Mitchell · Feb 24, 2026

Vir Biotechnology stock rocketed 55.4% today to $7.43, marking one of the biggest single-day...

Why Is Vir Biotechnology, Inc. Common Stock (VIR) Stock Up 71.4% Today?

Market News Alex Chen · Feb 24, 2026

Vir Biotechnology (VIR) stock rocketed 71.4% to $7.43, posting one of the day's largest biotech...

View All Coverage →

Get VIR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Vir Biotechnology, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.